BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33087016)

  • 21. TAFRO syndrome: A disease that known is half cured.
    Chen T; Feng C; Zhang X; Zhou J
    Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
    Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
    Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review.
    Akiyama M; Kaneko Y; Takeuchi T
    Ann Hematol; 2020 Nov; 99(11):2463-2475. PubMed ID: 32964342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
    Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
    Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
    Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
    Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tafro syndrome: Critical review for clinicians and pathologists.
    Paydas S
    Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [TAFRO syndrome and cutaneous necrotizing vasculitis].
    Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
    Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
    Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
    Fujimoto S; Kawabata H; Sakai T; Yanagisawa H; Nishikori M; Nara K; Ohara S; Tsukamoto N; Kurose N; Yamada S; Takai K; Aoki S; Masaki Y
    Int J Hematol; 2021 Jan; 113(1):73-80. PubMed ID: 32970275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International definition of iMCD-TAFRO: future perspectives.
    Nishimura Y; Nishimura MF; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
    Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
    Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
    Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
    Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
    Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
    Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.